18 PRIMECAP Management FibroGen Trades
PRIMECAP Management's position in FibroGen is currently worth $17.3 Million. That's 0.01% of their equity portfolio (226th largest holding). The investor owns 14.03% of the outstanding FibroGen stock. The first FibroGen trade was made in Q4 2019. Since then PRIMECAP Management bought shares twelve more times and sold shares on five occasions. The investor's estimated purchase price is $500 Million, resulting in a loss of 97%.
News about FibroGen Inc and PRIMECAP Management
PRIMECAP Management Adjusts Position in FibroGen Inc
PRIMECAP Management Adjusts Position in FibroGen Inc
UBS Asset Management Americas Inc. Has $2.19 Million Position in FibroGen, Inc. (NASDAQ:FGEN)
UBS Asset Management Americas Inc. reduced its position in shares of FibroGen, Inc. (NASDAQ:FGEN) by 13.2% in the 2nd quarter, according to the company in it...
FibroGen, Inc. (NASDAQ:FGEN) Position Boosted by Charles Schwab Investment Management Inc.
Charles Schwab Investment Management Inc. raised its holdings in shares of FibroGen, Inc. (NASDAQ:FGEN) by 2.9% during the 2nd quarter, according to the comp...